Enterade Launches Drink Under the Medical Food Category to Rehydrate Patients Undergoing Radiotherapy and Chemotherapy for Cancer
Enterade - R Drink Is All Natural and the First of Its Kind in Today's Market
(firmenpresse) - GAINESVILLE, FL -- (Marketwire) -- 08/27/12 -- Today, based on years of research, Enterade USA LLC brings to market a patented drink made of amino acids and salts for rehydration with a specific focus on cancer radiotherapy and chemotherapy patients. A first of its kind, Enterade - R is a medical food formulated to hydrate and soothe those currently undergoing radiotherapy and chemotherapy treatments.
The normal glucose mediated sodium absorption mechanism that is utilized for rehydration gets compromised during stressful conditions such as radiotherapy and chemotherapy. Enterade - R utilizes amino acid mediated electrolyte absorption to rehydrate patients under such stress. This drink will be sold online as a medical food and has to be taken based on a doctor's recommendation. Enterade - R provides hydration without glucose.
"We created this product to serve a specific patient group that needs rehydration," said Enterade CEO Hari Thrivikramji. "We wanted to make an impact in the lives of cancer patients undergoing radiotherapy and chemotherapy who encounter side effects such as vomiting and diarrhea requiring rehydration. We look forward to expanding our consumer base with a dietary supplement drink and a sports drink that will be launched in the near future."
The recommended dose of Enterade - R is two 8 oz bottles a day for optimal results. To purchase or learn more about Enterade - R, please call 1-855-ENTERADE or visit .
Please note that the statements about Enterade - R made in this press release have not been evaluated by the FDA. Enterade - R is not intended to diagnose, treat, cure or prevent any disease.
Enterade USA LLC is a company focused on health, nutrition and wellness based in Newberry, Florida. A science-based business engaged in research on transport mechanisms in the gastrointestinal system, the company utilizes sponsored research at the University of Florida to further its R&D initiatives.
Enterade USA LLC, works to bring to market health foods and medicines based on scientific research. The focus of the company is on correcting nutritional imbalances in patients undergoing radiotherapy, chemotherapy and in those suffering from inflammatory bowel disease. In addition, the company is also engaged in research on health foods for diabetics and elite athletes. Other areas of specific interest include Cystic Fibrosis and Rotavirus Diarrhea.
The company's mission is to use science from the lab to develop health foods and medicines that help a wide spectrum of individuals, from patients to athletes, maintain a healthy lifestyle. As is said in the Enterade slogan -- Making Science Work -- we bring science to work for you.
PR Contact:
Kendall Wayland
Uproar PR for Enterade
407-767-0452 x229
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 27.08.2012 - 07:04 Uhr
Sprache: Deutsch
News-ID 1145476
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
GAINESVILLE, FL
Phone:
Kategorie:
Beverages
Anmerkungen:
Diese Pressemitteilung wurde bisher 182 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Enterade Launches Drink Under the Medical Food Category to Rehydrate Patients Undergoing Radiotherapy and Chemotherapy for Cancer
"
steht unter der journalistisch-redaktionellen Verantwortung von
Enterade USA LLC (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
